BioSpace has been honored with major journalism awards recognizing its coverage during significant changes under President Trump. The publication reported extensively on FDA leadership turnover and legislative impacts affecting biopharma companies. Editor Lori Ellis was also recognized for mentorship within B2B journalism.
